Gloria Sovena

Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96.

L. Mariani, V. Mazzaferro, G. Parmiani, 2005, Cancer research.

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

P. Srivastava, A. Marchianò, M. Maio, 2006, Cancer Immunology, Immunotherapy.

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

T. Di Pucchio, P. Marchetti, E. Bonmassar, 2006, Cancer research.

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

L. Mariani, V. Chiarion-Sileni, M. Maio, 2012, Clinical Cancer Research.

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

A. Villa, G. Parmiani, S. Fais, 2006, Cancer research.

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

F. Marincola, R. Galli, E. Wang, 2010, Clinical Cancer Research.

Role of Cross-Talk between IFN-α-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens1

F. Belardelli, G. Parmiani, L. Rivoltini, 2004, The Journal of Immunology.